Showing results (351-360 of 438) with videos related to

Sort By:
Pageof 44
The Lancet. Neurology|February 7, 2012
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysisReisa Sperling, Stephen Salloway, David J Brooks, et al.
International Journal of Impotence Research|January 10, 2002
Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapismR Berger, K Billups, G Brock, et al.
The New England Journal of Medicine|January 24, 2014
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's diseaseStephen Salloway, Reisa Sperling, Nick C Fox, et al.
The Lancet. Neurology|May 25, 2019
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trialAdam L Boxer, Irfan Qureshi, Michael Ahlijanian, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Alzheimer's disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expressionAli S Ropri, Tiffany G Lam, Vrinda Kalia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Alzheimer's disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expressionAli S Ropri, Tiffany G Lam, Vrinda Kalia, et al.
Neurology|July 16, 2024
Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy BodiesDavid G Coughlin, Karen R MacLeod, John S Middleton, et al.
Nature Communications|April 9, 2025
GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tauDiana Acosta Ingram, Emir Turkes, Tae Yeon Kim, et al.
JAMA Neurology|September 19, 2022
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled TrialsSusanne Ostrowitzki, Tobias Bittner, Kaycee M Sink, et al.
Movement Disorders Clinical Practice|January 10, 2026
Voice and Speech in Atypical Parkinsonian DisordersFederico Rodriguez-Porcel, Farwa Ali, Michiko Bruno, et al.
Pageof 44